RISANAMENTO SPA financials
RISANAMENTO SPA
81560070BFE803A30458 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €134.0K | €595.6M |
| Other income | €579.0K | €6.3M |
| Employee benefits expense | €3.3M | €3.4M |
| Depreciation & amortisation | €274.0K | €1.0M |
| Operating profit (EBIT) | -€46.8M | €7.2M |
| Finance costs | €264.0K | €6.9M |
| Profit before tax | -€46.0M | €4.7M |
| Income tax expense | -€15.0K | -€7.1M |
| Profit for the year | -€47.5M | €10.6M |
| — attributable to owners | -€47.5M | €10.6M |
| — attributable to NCI | €0 | €0 |
| Total comprehensive income | -€47.5M | €10.6M |
| Per share | ||
| Basic EPS | €-0.03 | €0.01 |
| Free cash flow / share | €-0.02 | €0.02 |
| Cash flow statement | ||
| Net cash from operating activities | -€29.3M | €40.2M |
| Net cash from investing activities | -€4.0M | -€2.6M |
| Purchase of PP&E (capex) | €1.4M | €122.0K |
| Purchase of intangibles | €35.0K | €0 |
| Net cash from financing activities | €12.0K | €3.5M |
| Proceeds from borrowings | €12.0K | €6.6M |
| Repayments of borrowings | €0 | €3.1M |
| Balance sheet | ||
| Total assets | €151.5M | €175.3M |
| Non-current assets | €8.8M | €11.6M |
| Property, plant & equipment | €3.8M | €699.0K |
| Current assets | €142.3M | €161.8M |
| Inventories | €111.1M | €102.3M |
| Trade & other receivables | €14.0M | €9.1M |
| Cash & equivalents | €17.1M | €50.4M |
| Total equity | €5.2M | €52.6M |
| — attributable to owners | €5.2M | €52.6M |
| Non-controlling interests | €0 | €0 |
| Non-current liabilities | €61.0M | €52.9M |
| Current liabilities | €85.4M | €69.8M |
| Trade & other payables | €83.8M | €65.6M |
| Deferred tax liabilities | €3.0M | €3.0M |
| Derived metrics | ||
| Free cash flow | -€30.7M | €40.1M |
| Operating margin | -34923.9% | 1.2% |
| Net margin | -35414.9% | 1.8% |
| Return on equity | -918.6% | 20.2% |
| Cash conversion ratio | 0.62× | 3.77× |
| Capex coverage | -20.53× | 329.30× |
| Other reported items | ||
| Adjustments For Decrease Increase In Trade Account Receivable | -€5.0M | €13.5M |
| Adjustments For Deferred Tax Expense | -€1.0K | -€10.1M |
| Adjustments For Depreciation and Amortisation Expense | €274.0K | €1.0M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €1.6M | €10.4M |
| Adjustments For Increase Decrease In Trade Account Payable | €15.5M | €55.5M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €0 | -€40.5M |
| Adjustments For Provisions | €6.1M | -€10.4M |
| Basic Earnings Loss Per Share From Continuing Operations | €-0.03 | €0.01 |
| Basic Earnings Loss Per Share From Discontinued Operations | €-0.00 | €-0.00 |
| Changes In Inventories of Finished Goods and Work In Progress | -€384.0K | €544.8M |
| Comprehensive Income Attributable To Noncontrolling Interests | €0 | €0 |
| Comprehensive Income Attributable To Owners of Parent | -€47.5M | €10.6M |
| Current Financial Liabilities | €768.0K | €46.0K |
| Current Tax Liabilities Current | €865.0K | €4.2M |
| Deferred Tax Assets | €0 | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €0 | €0 |
| Equity and Liabilities | €151.5M | €175.3M |
| Finance Income | €1.0M | €4.4M |
| Increase Decrease In Cash and Cash Equivalents | -€33.3M | €41.1M |
| Intangible Assets Other Than Goodwill | €54.0K | €69.0K |
| Investment Accounted For Using Equity Method | €100.0K | €100.0K |
| Investment Property | €0 | €8.4M |
| Liabilities | €146.4M | €122.7M |
| Noncurrent Financial Liabilities | €2.0M | €65.0K |
| Noncurrent Provisions For Employee Benefits | €1.8M | €2.3M |
| Operating Expense Excluding Cost of Sales | €33.3M | €3.2M |
| Other Comprehensive Income | €0 | €0 |
| Other Longterm Provisions | €54.2M | €47.6M |
| Other Noncurrent Nonfinancial Assets | €4.9M | €2.4M |
| Other Noncurrent Nonfinancial Liabilities | €0 | €0 |
| Profit Loss From Continuing Operations | -€46.0M | €11.7M |
| Profit Loss From Discontinued Operations | -€1.4M | -€1.1M |
| Revenue and Operating Income | €1.1M | €57.1M |
| Services Expense | €10.9M | €20.6M |
Every line item above is a fact tagged in RISANAMENTO SPA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.